(Q53173084)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531293%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Inhibition of c-MET is a potential therapeutic strategy for treatment of diffuse large B-cell lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531293%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531293%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Prashant Bavi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531293%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Azhar R Hussain

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531293%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Maqbool Ahmed

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531293%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Fouad Al-Dayel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531293%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Rong Bu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531293%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Khawla S Al-Kuraya

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531293%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

7 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531293%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531293%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531293%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531293%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

1346-1356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531293%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.2010.108

5 February 2020

exact match

0 references

cites work

Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

High serum hepatocyte growth factor level in patients with non‐Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Inhibition of phosphatidylinositol 3'-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Curcumin induces apoptosis via inhibition of PI3'-kinase/AKT pathway in acute T cell leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Proteasome inhibitor MG-132 mediated expression of p27Kip1 via S-phase kinase protein 2 degradation induces cell cycle coupled apoptosis in primary effusion lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

7 January 2021

Prognostic significance of hepatocyte growth factor and c-MET expression in patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

7 January 2021

Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

7 January 2021

X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

7 January 2021

c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.108

7 January 2021